Printer Friendly


India: A proposed agreement with the US promises to increase the availability of micro-organisms and biological materials in India. Indian researchers complain that requests sent to the American Type Tissue Collection public database are often delayed or unanswered. The impact has been especially acute on vaccine development. The new agreement discussed by India's Science Minister, Kapil Sibal, and US Deputy Secretary of Commerce, David A. Sampson, would enable India's Department of Biotechnology to obtain biological materials and guarantee they will not be used for terrorism. It also includes export provisions similar to those for nuclear technology. However, India's researchers will still have to contend with the high price of biological materials, such as yeast, viruses, expression systems, and a lack of documentation for source materials, which could jeopardize patents on products developed using them_

Source: Nature Biotechnology
COPYRIGHT 2005 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:agreement with United States to increase the availability of biological materials
Comment:India.(agreement with United States to increase the availability of biological materials)
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 30, 2005
Previous Article:Europe.
Next Article:Malta.

Related Articles
The real reasons for the second amendment of the Indian Patent Act. (The Monsanto Amendment).
Security Cooperation with the Pacific.
The FMCT: temptation and dashed hopes at the Conference on Disarmament.
Influenza virus samples, international law, and global health diplomacy.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |